| Metric | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue | 9.8B -0.5% | 9.8B +8.8% | 9.0B +0.6% | 9.0B +4.5% | 8.6B |
| Cost of Revenue | 3.4B +0.5% | 3.4B +4.2% | 3.3B +6.5% | 3.1B +2.0% | 3.0B |
| Gross Profit | 6.3B -1.1% | 6.4B +11.3% | 5.8B -2.4% | 5.9B +5.8% | 5.6B |
| Operating Expenses | 4.6B -1.9% | 4.7B +9.5% | 4.3B +1.6% | 4.2B +1.4% | 4.1B |
| R&D | 771.0M +14.9% | 671.0M -7.1% | 722.0M -4.2% | 754.0M +3.9% | 726.0M |
| SG&A | 3.2B +4.6% | 3.1B +3.4% | 3.0B -0.3% | 3.0B +5.7% | 2.8B |
| Operating Income | 1.8B +1.0% | 1.7B +16.6% | 1.5B -12.3% | 1.7B +18.3% | 1.4B |
| EBITDA | 2.6B -4.8% | 2.7B +15.9% | 2.3B -5.6% | 2.5B +8.8% | 2.3B |
| Net Income | 1.5B +17.6% | 1.3B +9.5% | 1.1B -16.9% | 1.4B +32.0% | 1.0B |
| EPS (Basic) | $1.15 +18.6% | $0.97 +9.0% | $0.89 -16.8% | $1.07 +32.1% | $0.81 |
| EPS (Diluted) | $1.14 +17.5% | $0.97 +9.0% | $0.89 -16.8% | $1.07 +32.1% | $0.81 |
| Shares (Diluted) | 1.3B -0.2% | 1.3B -0.1% | 1.3B +0.1% | 1.3B +0.1% | 1.3B |